Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer.
about
Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activityAttachment and fusion inhibitors potently prevent dendritic cell-driven HIV infectionRole of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.Immunoglobulins drive terminal maturation of splenic dendritic cells.A fusion inhibitor prevents spread of immunodeficiency viruses, but not activation of virus-specific T cells, by dendritic cells.Pre-clinical development as microbicide of zinc tetra-ascorbo-camphorate, a novel terpenoid derivative: potent in vitro inhibitory activity against both R5- and X4-tropic HIV-1 strains without significant in vivo mucosal toxicity.Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?Biology of HIV mucosal transmission.Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G.HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting CellsPotential of carbohydrate-binding agents as therapeutics against enveloped viruses.Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus.Carbohydrates on HIV: mediators of immune evasion and targets for antiviral intervention
P2860
Q21562543-A9537FA1-39B2-477E-8A55-E6B287AB9BDBQ34574462-2B05AD3D-394B-49C8-B8A2-83A97AC21374Q34760408-4CBD2BEB-2C4F-4540-8418-2B19DF42F643Q36598313-179A47E5-4BF7-455A-BD0B-0D9515D949BBQ36673272-373E1FAB-5392-4E2C-9140-EE18BD8D33A2Q36717804-D11BE905-657C-43E5-861F-9F2AD2200653Q36758492-AC41C194-B63A-4C4E-9650-09530C2A3CCCQ36890951-2DF5B8C0-2D8C-4106-AC31-0F2113AC2BBEQ37033387-A1ABE724-1B4F-410C-B296-D33B7CF17925Q37287774-A5B1CA86-FE10-4C9B-BBB5-4A40C1E08CA0Q37767654-978D4335-BFDA-4C58-B950-831A1A291EB6Q54212657-B75A343D-8393-49A3-B59E-4E1C0B95E60BQ57252416-6BF9647A-84F3-446F-9DD1-299CAD5EE6A3
P2860
Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Sugar-binding proteins potentl ...... -cell-directed HIV-1 transfer.
@ast
Sugar-binding proteins potentl ...... -cell-directed HIV-1 transfer.
@en
Sugar-binding proteins potentl ...... immunodeficiency virus type 1
@nl
type
label
Sugar-binding proteins potentl ...... -cell-directed HIV-1 transfer.
@ast
Sugar-binding proteins potentl ...... -cell-directed HIV-1 transfer.
@en
Sugar-binding proteins potentl ...... immunodeficiency virus type 1
@nl
prefLabel
Sugar-binding proteins potentl ...... -cell-directed HIV-1 transfer.
@ast
Sugar-binding proteins potentl ...... -cell-directed HIV-1 transfer.
@en
Sugar-binding proteins potentl ...... immunodeficiency virus type 1
@nl
P2860
P50
P1433
P1476
Sugar-binding proteins potentl ...... -cell-directed HIV-1 transfer.
@en
P2093
Stuart G Turville
P2860
P304
13519-13527
P356
10.1128/JVI.79.21.13519-13527.2005
P407
P577
2005-11-01T00:00:00Z